According to the company, Elzofri is the first patented long-acting injectable paliperidone palmitate developed in China and approved by the FDA for the treatment of schizophrenia and schizoaffective disorder.
FDA Approves Luye Pharma Group’s Erzofri for Adult Patients with Schizophrenia and Schizoaffective Disorder
You Might Also Like
Leave a Comment
Latest News
Recent Posts
- Progress of metal cutting technology: Innovative innovation, sustainability, and future labor
- Ceratizit showcases innovation, sustainability and cutting-edge solutions at IMTEX 2025
- Goldman launches an internal GEN AI Assistant with 10K employees
- Taiwan emerges as key player in Indian machine tools market with 20.8% growth
- Automobile companies battle AI bots and recruitment competition